Prognostic Performance of RECIP 1.0 Based on [
PCWG3
PET/CT
PSMA
RECIP
[177Lu]Lu-PSMA I&T
[18F]PSMA-1007
Journal
Journal of nuclear medicine : official publication, Society of Nuclear Medicine
ISSN: 1535-5667
Titre abrégé: J Nucl Med
Pays: United States
ID NLM: 0217410
Informations de publication
Date de publication:
07 Mar 2024
07 Mar 2024
Historique:
received:
19
09
2023
revised:
05
01
2024
medline:
8
3
2024
pubmed:
8
3
2024
entrez:
7
3
2024
Statut:
aheadofprint
Résumé
In metastatic castration-resistant prostate cancer (mCRPC) patients treated with prostate-specific membrane antigen (PSMA)-targeted radioligand therapy (RLT), the recently proposed criteria for evaluating response to PSMA PET (RECIP 1.0) based on
Identifiants
pubmed: 38453363
pii: jnumed.123.266702
doi: 10.2967/jnumed.123.266702
pii:
doi:
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Informations de copyright
© 2024 by the Society of Nuclear Medicine and Molecular Imaging.